National Research/$NRC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About National Research

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

Ticker

$NRC
Primary listing

Industry

Health Care Providers & Services

Employees

368

ISIN

US6373722023

NRC Metrics

BasicAdvanced
$381M
16.41
$1.02
0.36
$0.48
2.87%

Bulls say / Bears say

National Research Corporation (NRC) has demonstrated a high Return on Equity (ROE) of 72.69%, indicating efficient management and strong profitability. (directorstalkinterviews.com)
The company has been honored as a 2025 CSO Award winner by CSO Online for its outstanding leadership in cybersecurity, AI safety, and healthcare data, enhancing its reputation and investor confidence. (ainvest.com)
NRC's stock has shown a notable upward trend, with shares rising in 7 of the last 10 days, contributing to a 20.68% gain over the past two weeks, indicating growing investor interest. (ainvest.com)
NRC reported a 5% decline in revenues for Q1 2025 compared to the previous year, indicating potential challenges in maintaining growth. (nasdaq.com)
The company's net income for Q1 2025 declined by 9% year-over-year, reflecting operational pressures amid lower revenue and higher interest costs. (nasdaq.com)
NRC's stock price has experienced significant volatility, with a 70% decline over the past year, raising concerns about its stability and investor confidence. (simplywall.st)
Data summarised monthly by Lightyear AI. Last updated on 10 Jul 2025.

NRC Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NRC

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Jul11
National Research
Dividend·Payment
$0.12Per share
FAQs